During the past decade, Clinica de la Mujer conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica de la Mujer" #1 sponsor was "Corvus Pharmaceuticals, Inc." with 1 trials, followed by "Janssen Research & Development, LLC" with 1 trials sponsored, "NORCE Norwegian Research Centre AS" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Shenyang Tonglian Group CO., Ltd" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica de la Mujer" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Clinica de La Mujer" with 1 trials as a collaborator, "Haukeland University Hospital" with 1 trials as a collaborator, "Hospital Fernandez" with 1 trials as a collaborator and "Hospital Materno Infantil Ramón Sardá" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Clinica de la Mujer" are "Crohn's Disease" (2 trials), "COVID-19" (1 trials), "Coronavirus Disease 2019" (1 trials), "Covid-19" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Clinica de la Mujer" in a lesser frequency.

Most popular intervention types in "Clinica de la Mujer" are "Drug" (6 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "CPI-006 1 mg/kg + SOC" (1 trials), "CPI-006 2 mg/kg + SOC" (1 trials), "Carrimycin" (1 trials) and "Etrasimod" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica de la Mujer" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Clinica de la Mujer". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinica de la Mujer, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica de la Mujer, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".